No items found.

Clearway 2

Airway Clearance
Get the
Clearway 2
Download the brochure to get more details about the product.

Product Information Overview

Overview

Breas ClearWay 2  Mechanical Insufflation-Exsufflation Device
Overview

The Breas ClearWay is a second-generation Mechanical Insufflation-Exsufflation (MI-E) device designed to support patients with impaired airway clearance. By alternating positive and negative pressures, it simulates a natural cough, helping to mobilize and remove mucus secretions safely and effectively. ClearWay 2 is widely used in patients with neuromuscular disorders, cystic fibrosis, and other chronic respiratory conditions across both hospital and homecare settings.

Key Benefits
  • Advanced Titration with TreatRepeat® – Allows clinicians to deliver customized cycles of insufflation/exsufflation and save them as automated treatment routines.
  • Enhanced Patient Synchrony
    • iTrigger® with eSync: Provides precise flow-triggered cycles.
    • Synchrony Beep®: Audio cue before exsufflation, helping patients sync breathing even without visual cues.
  • Versatile Therapy Modes – Operates in Manual, IPPB, Basic Automatic, Programmable, and NIV modes, adapting to individual patient needs.
  • User-Friendly Interface – Intuitive touchscreen plus optional handheld remote, foot pedal, and integrated SpO₂ monitoring.
  • Comprehensive Monitoring & Connectivity – Displays cough peak flow, insufflation volume, pressure, flow, SpO₂, heart rate, and therapy session data. Records can be exported via Ethernet, USB, SD card, or cloud platforms.
  • Portable & Quiet – Lightweight (~3.85 kg), compact (285 × 280 × 200 mm), and low-noise (30–35 dB(A)) for comfort at home or in clinical environments.
  • Customizable Therapy – Stores up to 4 individual patient profiles for rapid, consistent therapy initiation.
Clinical Use
The Breas ClearWay 2 is intended for patients with weak or ineffective cough and secretion retention due to conditions such as:
  • Neuromuscular disorders (e.g., ALS, muscular dystrophy, spinal muscular atrophy)
  • Cystic fibrosis
  • Progressive neuromuscular diseases
  • Other chronic respiratory conditions

Therapeutic Role

  • Enhances cough strength and secretion clearance
  • Reduces the risk of respiratory infections and complications
  • Supports both acute treatment and long-term maintenance therapy

Clinical Settings

  • Hospitals: Respiratory wards, ICUs, and rehabilitation units
  • Homecare: Suitable for frequent or prolonged airway clearance at home
  • Rehabilitation: Effective for long-term management of chronic airway conditions